Laurence Reid, Director at Metagenomi Therapeutics, bought MGX on Sep 9, 2026
Data as of Oct 16
- Traded
- Sep 9, 2026
- Disclosed
- Sep 11, 2026
- Filed
- 2 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
MGX since disclosure
−32.4%
Similar stocks (XLV) since disclosure
+6.9%
XLV — its sector index fund
Change in closing price from Sep 11, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▲ BUYLaurence Reid DirectorMGX Metagenomi Therapeutics, Inc.$138disclosed Sep 11 · filed 2 days after the trade